Clinical Trials Directory

Trials / Conditions / Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma

Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma

8 registered clinical trials studyying Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma.

StatusTrialSponsorPhase
SuspendedZanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma
NCT04850495
Yazeed SawalhaPhase 1
SuspendedTesting CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diag
NCT04799275
National Cancer Institute (NCI)Phase 2 / Phase 3
Active Not RecruitingAcalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma
NCT04257578
University of WashingtonPhase 1 / Phase 2
Active Not Recruiting19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers
NCT04464200
Memorial Sloan Kettering Cancer CenterPhase 1
CompletedDuvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma
NCT03892044
David Bond, MDPhase 1
SuspendedNivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma
NCT03704714
Northwestern UniversityPhase 1 / Phase 2
Active Not RecruitingTesting the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immunotherapy Dr
NCT03321643
National Cancer Institute (NCI)Phase 1
CompletedAvelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or
NCT03440567
City of Hope Medical CenterPhase 1